Multiple Class I Peptides & Montanide ISA 51 VG w Escalating Doses of Anti-PD-1 ab BMS936558
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01176461 |
Recruitment Status :
Active, not recruiting
First Posted : August 6, 2010
Last Update Posted : April 21, 2021
|
Sponsor:
H. Lee Moffitt Cancer Center and Research Institute
Collaborators:
National Cancer Institute (NCI)
Bristol-Myers Squibb
Medarex
Information provided by (Responsible Party):
H. Lee Moffitt Cancer Center and Research Institute
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Actual Primary Completion Date : | December 12, 2016 |
Estimated Study Completion Date : | December 2021 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):